• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身炎症反应指数与预后营养指数联合评估对结直肠癌患者的预后价值

Prognostic value of combined systemic inflammation response index and prognostic nutritional index in colorectal cancer patients.

作者信息

Li Ke-Jin, Zhang Zi-Yi, Sulayman Subinur, Shu Yin, Wang Kuan, Ababaike Saibihutula, Zeng Xiang-Yue, Zhao Ze-Liang

机构信息

Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang Uygur Autonomous Region, China.

出版信息

World J Gastrointest Surg. 2024 Dec 27;16(12):3794-3805. doi: 10.4240/wjgs.v16.i12.3794.

DOI:10.4240/wjgs.v16.i12.3794
PMID:39734462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11650238/
Abstract

BACKGROUND

The prognosis of colorectal cancer (CRC) patients is notably influenced by both inflammation and nutritional status. The prognostic nutritional index (PNI) and systemic inflammatory response index (SIRI) have been reported in prognostic studies of various tumors. However, the efficacy of the combination of the two in predicting the prognosis of CRC patients has not been studied.

AIM

To evaluate the effectiveness of PNI and SIRI in predicting the prognosis of patients with CRC.

METHODS

We retrospectively gathered data from 470 CRC patients who underwent feasible radical surgery at Xinjiang Cancer Hospital. The optimal cut-off values for SIRI and PNI, along with their predictive power for survival, were determined through area under the receiver operating characteristic curve using time-dependent receiver operating characteristic analysis. The Kaplan-Meier method and log-rank test were applied to assess prognostic impact, and a multifactorial Cox proportional hazards model was employed for analysis. Additionally, a new model, PSIRI, was developed and assessed for its survival prediction capability.

RESULTS

The optimal cutoff values for PNI and SIRI were determined to be 47.80 and 1.38, respectively. Based on these values, patients were categorized into high PNI and low PNI groups, as well as high SIRI and low SIRI groups. Significant differences in age, T stage, neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) subgroups were observed between the PNI groups in the baseline profile. In the SIRI group, notable differences were found in gender, T stage, nerve invasion, intravascular tumor emboli, NLR, MLR, and PLR subgroups. Both low PNI and high SIRI were identified as independent risk factors for poor prognosis in CRC patients. When combined into the PSIRI model, it was shown that patients with a PSIRI ≤ 1 had a higher risk of death compared to those with a PSIRI of 2.

CONCLUSION

We assessed the impact of PNI and SIRI on the prognostic survival of CRC patients and developed a new model, PSIRI. This model demonstrated superior predictive accuracy, with a concordance index of 0.767.

摘要

背景

结直肠癌(CRC)患者的预后受到炎症和营养状况的显著影响。预后营养指数(PNI)和全身炎症反应指数(SIRI)已在各种肿瘤的预后研究中有所报道。然而,两者联合在预测CRC患者预后方面的效果尚未得到研究。

目的

评估PNI和SIRI在预测CRC患者预后方面的有效性。

方法

我们回顾性收集了新疆肿瘤医院470例行可行根治性手术的CRC患者的数据。通过时间依赖性受试者工作特征分析,利用受试者工作特征曲线下面积确定SIRI和PNI的最佳截断值及其对生存的预测能力。采用Kaplan-Meier法和对数秩检验评估预后影响,并使用多因素Cox比例风险模型进行分析。此外,开发了一种新模型PSIRI,并评估其生存预测能力。

结果

PNI和SIRI的最佳截断值分别确定为47.80和1.38。基于这些值,患者被分为高PNI组和低PNI组,以及高SIRI组和低SIRI组。在基线资料中,PNI组之间在年龄、T分期、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和血小板与淋巴细胞比值(PLR)亚组方面存在显著差异。在SIRI组中,在性别、T分期、神经侵犯、血管内肿瘤栓子、NLR、MLR和PLR亚组方面发现了显著差异。低PNI和高SIRI均被确定为CRC患者预后不良的独立危险因素。当合并到PSIRI模型中时,结果显示PSIRI≤1的患者比PSIRI为2的患者死亡风险更高。

结论

我们评估了PNI和SIRI对CRC患者预后生存的影响,并开发了一种新模型PSIRI。该模型显示出卓越的预测准确性,一致性指数为0.767。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/caa2679e61de/WJGS-16-3794-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/7569098f00e3/WJGS-16-3794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/231fa2dc7e42/WJGS-16-3794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/45631b289fc4/WJGS-16-3794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/a1c8c00958ca/WJGS-16-3794-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/caa2679e61de/WJGS-16-3794-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/7569098f00e3/WJGS-16-3794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/231fa2dc7e42/WJGS-16-3794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/45631b289fc4/WJGS-16-3794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/a1c8c00958ca/WJGS-16-3794-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/11650238/caa2679e61de/WJGS-16-3794-g005.jpg

相似文献

1
Prognostic value of combined systemic inflammation response index and prognostic nutritional index in colorectal cancer patients.全身炎症反应指数与预后营养指数联合评估对结直肠癌患者的预后价值
World J Gastrointest Surg. 2024 Dec 27;16(12):3794-3805. doi: 10.4240/wjgs.v16.i12.3794.
2
Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.联合全身炎症反应指数和预后营养指数预测接受根治性放疗的局部晚期老年食管鳞状细胞癌患者的预后。
J Gastrointest Oncol. 2022 Feb;13(1):13-25. doi: 10.21037/jgo-21-784.
3
Inflammation-related markers and prognosis of alpha-fetoprotein producing gastric cancer.甲胎蛋白产生型胃癌的炎症相关标志物与预后
World J Gastrointest Oncol. 2024 Sep 15;16(9):3875-3886. doi: 10.4251/wjgo.v16.i9.3875.
4
Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer.术前全身免疫炎症指数和预后营养指数对上皮性卵巢癌患者的预测价值。
J Ovarian Res. 2025 Mar 7;18(1):45. doi: 10.1186/s13048-025-01631-4.
5
Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.早期低-中分化宫颈鳞癌患者炎症和营养标志物的预后价值。
Cancer Control. 2023 Jan-Dec;30:10732748221148913. doi: 10.1177/10732748221148913.
6
Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.全身炎症反应指数在接受术前新辅助化疗的肝母细胞瘤患者中的预后价值
Front Oncol. 2023 Oct 13;13:1276175. doi: 10.3389/fonc.2023.1276175. eCollection 2023.
7
Preoperative inflammation and nutrition-based comprehensive biomarker for predicting prognosis in resectable colorectal cancer.用于预测可切除结直肠癌预后的术前基于炎症和营养的综合生物标志物。
Front Oncol. 2023 Nov 22;13:1279487. doi: 10.3389/fonc.2023.1279487. eCollection 2023.
8
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.术前全身免疫炎症指数和预后营养指数对食管鳞癌患者的预测价值。
J Cell Physiol. 2019 Feb;234(2):1794-1802. doi: 10.1002/jcp.27052. Epub 2018 Aug 2.
9
Predicting the prognosis of patients with renal cell carcinoma based on the systemic immune inflammation index and prognostic nutritional index.基于全身免疫炎症指数和预后营养指数预测肾细胞癌患者的预后。
Sci Rep. 2024 Oct 23;14(1):25045. doi: 10.1038/s41598-024-76519-2.
10
Prognostic value of the systemic inflammation response index in patients with aneurismal subarachnoid hemorrhage and a Nomogram model construction.全身炎症反应指数对动脉瘤性蛛网膜下腔出血患者的预后价值及列线图模型构建。
Br J Neurosurg. 2023 Dec;37(6):1560-1566. doi: 10.1080/02688697.2020.1831438. Epub 2020 Oct 12.

引用本文的文献

1
Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Colorectal Cancer Survival: A Multicenter Retrospective Cohort Study.CRP-白蛋白-淋巴细胞(CALLY)指数对结直肠癌生存的预后价值:一项多中心回顾性队列研究
J Gastrointest Cancer. 2025 Sep 5;56(1):183. doi: 10.1007/s12029-025-01307-8.
2
Significant association between systemic inflammation response index and prognosis in patients with urological malignancies.泌尿系统恶性肿瘤患者全身炎症反应指数与预后的显著关联。
Front Immunol. 2025 Feb 26;16:1518647. doi: 10.3389/fimmu.2025.1518647. eCollection 2025.
3
Diagnostic value of peripheral blood inflammatory indices for clinicopathological profile of colorectal cancer: a retrospective observational study.

本文引用的文献

1
Elevated BEAN1 expression correlates with poor prognosis, immune evasion, and chemotherapy resistance in rectal adenocarcinoma.BEAN1表达升高与直肠腺癌的预后不良、免疫逃逸和化疗耐药相关。
Discov Oncol. 2024 Sep 14;15(1):446. doi: 10.1007/s12672-024-01321-5.
2
Research progress on predictive models for malnutrition in cancer patients.癌症患者营养不良预测模型的研究进展
Front Nutr. 2024 Aug 21;11:1438941. doi: 10.3389/fnut.2024.1438941. eCollection 2024.
3
Prognostic genome and transcriptome signatures in colorectal cancers.
外周血炎症指标对结直肠癌临床病理特征的诊断价值:一项回顾性观察研究
BMC Gastroenterol. 2025 Mar 3;25(1):127. doi: 10.1186/s12876-025-03681-w.
结直肠癌的预后基因组和转录组特征。
Nature. 2024 Sep;633(8028):137-146. doi: 10.1038/s41586-024-07769-3. Epub 2024 Aug 7.
4
GNL3L exhibits pro-tumor activities via NF-κB pathway as a poor prognostic factor in acute myeloid leukemia.GNL3L通过NF-κB信号通路表现出促肿瘤活性,是急性髓系白血病预后不良的一个因素。
J Cancer. 2024 May 30;15(13):4072-4080. doi: 10.7150/jca.95339. eCollection 2024.
5
Research trends and hotspots in surgical treatment of recurrent nasopharyngeal carcinoma: A bibliometric analysis from 2000 to 2023.复发性鼻咽癌外科治疗的研究趋势与热点:2000年至2023年的文献计量分析
Asian J Surg. 2024 Jun;47(6):2939-2941. doi: 10.1016/j.asjsur.2024.02.106. Epub 2024 Mar 2.
6
Chronic inflammation and cancer; the two sides of a coin.慢性炎症与癌症:一枚硬币的两面。
Life Sci. 2024 Feb 1;338:122390. doi: 10.1016/j.lfs.2023.122390. Epub 2023 Dec 30.
7
Potential promising anticancer applications of β-glucans: a review.β-葡聚糖在抗癌方面的潜在应用:综述。
Biosci Rep. 2024 Jan 31;44(1). doi: 10.1042/BSR20231686.
8
Sarcopenia predicts postoperative complications and survival in colorectal cancer patients with GLIM-defined malnutrition: Analysis from a prospective cohort study.肌肉减少症预测 GLIM 定义的营养不良的结直肠癌患者的术后并发症和生存:来自前瞻性队列研究的分析。
Eur J Surg Oncol. 2024 Jan;50(1):107295. doi: 10.1016/j.ejso.2023.107295. Epub 2023 Nov 23.
9
POEMS syndrome in the 21st century: A bibliometric analysis.21世纪的POEMS综合征:一项文献计量分析。
Heliyon. 2023 Oct 4;9(10):e20612. doi: 10.1016/j.heliyon.2023.e20612. eCollection 2023 Oct.
10
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition.波形蛋白促进神经胶质瘤的进展并维持神经胶质瘤细胞对氧化磷酸化抑制的抗性。
Cell Oncol (Dordr). 2023 Dec;46(6):1791-1806. doi: 10.1007/s13402-023-00844-3. Epub 2023 Aug 30.